他汀类药物在冠心病合并糖尿病患者治疗中的应用
[摘要] 目的 探讨他汀类药物在冠心病合并糖尿病患者治疗中的应用与效果。方法 选取该科2016年11月”2017年11月收治的冠心病合并糖尿病患者128例，随机分为两组各64例，对照组给予常规治疗，观察组在对照组的基础上给予他汀类药物。结果 治疗后观察组FPG（5.21±0.78）mmol/L、TC（5.35±0.16）mmol/L、TG（1.18±0.44）mmol/L、LDL-C（2.79±0.19）mmol/L较对照组显著降低，HDL-C（1.88±0.33）mmol/L较对照组显著升高（P<0.05）；观察组不良事件发生率为7.8%，明显少于对照组21.9%（P<0.05）。结论 对冠心病合并糖尿病患者给予他汀类药物，可有效降低血脂水平，减少心血管不良事件的发生，值得应用。
[关键词] 他汀类；冠心病；糖尿病
[中图分类号] R587.1 [文献标识码] A [文章编号] 1672-4062（2018）02（b）-0078-02
Application of Statins in the Treatment of Coronary Heart Disease Complicated with Diabetes
CUI Wen-zhang
Department of Cardiovascular Medicine， Jilin People"s Hospital， Changchun， Jilin Province， 130000 China
[Abstract] Objective This paper tries to investigate the application and effect of statins in the treatment of patients with coronary heart disease and diabetes. Methods 128 patients with coronary heart disease and diabetes mellitus admitted to this hospital from November 2016 to November 2017 were selected and were randomly divided into two groups of 64 patients in each. The control group was given conventional treatment. The observation group was given statins based on the control group. Results After treatment， FPG （5.21±0.78）mmol/L， TC （5.35±0.16）mmol/L， TG （1.18±0.44）mmol/L， and LDL-C （2.79±0.19）mmol/L were significantly lower in the observation group than in the control group. HDL-C（1.88±0.33）mmol/L was significantly higher than that in the control group（P<0.05）. The incidence of adverse events in the observation group was 7.8%， which was significantly less than 21.9% ...
|
== 试读已结束，如需继续阅读敬请充值会员 ==
|
|
本站文章均为原创投稿，仅供下载参考，付费用户可查看完整且有格式内容！
(费用标准：38元/2月，98元/2年，微信支付秒开通！) |
| 升级为会员即可查阅全文 。如需要查阅全文，请 免费注册 或 登录会员 |
|
